{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:51:44Z","timestamp":1793958704237,"version":"4.8.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99445-3","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:34:10Z","timestamp":1745570050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of serum calprotectin levels in patients with polycystic ovary syndrome"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-5486","authenticated-orcid":false,"given":"R\u0131fat","family":"\u015eener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-5106","authenticated-orcid":false,"given":"S\u00fcleyman Erkan","family":"Alata\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-8604","authenticated-orcid":false,"given":"\u00d6mer Tolga","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"99445_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein, I. F. & Leventhal, N. L. Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29, 181 (1935).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"99445_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","volume":"23","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi, H. M. et al. Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. Int. J. Mol. Sci. 23 (2), 583. https:\/\/doi.org\/10.3390\/ijms23020583 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"99445_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","volume":"12","author":"M Di Lorenzo","year":"2023","unstructured":"Di Lorenzo, M. et al. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): A comprehensive review. Curr. Nutr. Rep. 12 (3), 527\u2013544. https:\/\/doi.org\/10.1007\/s13668-023-00479-8 (2023).","journal-title":"Curr. Nutr. Rep."},{"issue":"1","key":"99445_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser, B. C. et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil. Steril. 97 (1), 28\u201338 (2012).","journal-title":"Fertil. Steril."},{"issue":"9","key":"99445_CR5","doi-asserted-by":"publisher","first-page":"e00617","DOI":"10.14309\/ctg.0000000000000617","volume":"14","author":"N Kapel","year":"2023","unstructured":"Kapel, N. et al. Fecal calprotectin for the diagnosis and management of inflammatory bowel diseases. Clin. Transl Gastroenterol. 14 (9), e00617. https:\/\/doi.org\/10.14309\/ctg.0000000000000617 (2023).","journal-title":"Clin. Transl Gastroenterol."},{"key":"99445_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"108","author":"J Langhorst","year":"2008","unstructured":"Langhorst, J. et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel disease: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP and clinical indices. Am. J. Gastroenterol. 108, 162\u2013169 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"99445_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3892\/ijmm.2021.4999","volume":"48","author":"S Yao","year":"2021","unstructured":"Yao, S. et al. Role of the S100 protein family in liver disease. Int. J. Mol. Med. 48, 166. https:\/\/doi.org\/10.3892\/ijmm.2021.4999 (2021).","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"99445_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR Eshre","year":"2004","unstructured":"Eshre, T. R. & Group, A. S. P. C. W. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81 (1), 19\u201325 (2004).","journal-title":"Fertil. Steril."},{"issue":"2","key":"99445_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5001\/omj.2009.25","volume":"24","author":"A Mahde","year":"2009","unstructured":"Mahde, A., Shaker, M. & Al-Mashhadani, Z. Study of Omentin1 and other adipokines and hormones in PCOS patients. Oman Med. J. 24 (2), 108\u2013118. https:\/\/doi.org\/10.5001\/omj.2009.25 (2009).","journal-title":"Oman Med. J."},{"issue":"2","key":"99445_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/ijem.IJEM_637_18","volume":"23","author":"G Sachdeva","year":"2019","unstructured":"Sachdeva, G. et al. Obese and Non-obesemPolycystic ovarian syndrome: comparison of clinical, metabolic, hormonalmparameters, and their differential response to clomiphene. Indian J. Endocrinol. Metab. 23 (2), 257\u2013262. https:\/\/doi.org\/10.4103\/ijem.IJEM_637_18 (2019).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"99445_CR11","doi-asserted-by":"publisher","unstructured":"Aghdashi, M. A. et al. Evaluation of serum calprotectin level and disease activity in patients with rheumatoid arthritis. Curr. Rheumatol. Rev. 1 (1). https:\/\/doi.org\/10.2174\/1573397115666190122113221 (2019).","DOI":"10.2174\/1573397115666190122113221"},{"issue":"2","key":"99445_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/0004563216653762","volume":"54","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. Calprotectin is a potential prognostic marker for polycystic ovary syndrome. Ann. Clin. Biochem. 54 (2), 253\u2013257. https:\/\/doi.org\/10.1177\/0004563216653762 (2017).","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"99445_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1210\/jc.2003-030932","volume":"89","author":"JS Laven","year":"2004","unstructured":"Laven, J. S. et al. Antimullerian hormone serum concentrations in Normoovulatory and anovulatory women. J. Clin. Endocrinol. Metab. 89 (1), 318\u2013323 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"99445_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/cen.13934","volume":"90","author":"MT Le","year":"2019","unstructured":"Le, M. T., Le, V. N. S., Le, D. D. & Net Exploration of the role of anti-Mullerian hormone and LH\/FSH ratio in diagnosis of polycystic ovary syndrome. Clin. Endocrinol. (Oxf). 90 (4), 579\u2013585. https:\/\/doi.org\/10.1111\/cen.13934 (2019).","journal-title":"Clin. Endocrinol. (Oxf)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99445-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99445-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99445-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:34:11Z","timestamp":1745570051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99445-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99445"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99445-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was gained from the Pamukkale Univercity Clinical Research Ethics Board (No:60116787-020\/24503).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"14471"}}